Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.

about

Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q55433994

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@en

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@nl

type

Item

label

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@en

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@nl

prefLabel

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@en

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@nl

P1476

Serelaxin, recombinant human r ...... atic review and meta-analysis.

@en

P2093

Fengzhen Yao

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Lijuan Cao

http://www.w3.org/2001/XMLSchema#string

Ling Yu

http://www.w3.org/2001/XMLSchema#string

Yabin Zhou

http://www.w3.org/2001/XMLSchema#string

Zhongyi Li

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Decongestion: Diuretics and other therapies for hospitalized heart failure

Predicting mortality in patients with acute heart failure: Role of risk scores

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.

Relaxin: review of biology and potential role in treating heart failure.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure.

A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.

Cardiovascular effects of relaxin: from basic science to clinical therapy.

P304

e11010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000011010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29923986

http://www.w3.org/2001/XMLSchema#string

P932

6023957

http://www.w3.org/2001/XMLSchema#string